NG Test® SARS-CoV-2 Ag for the qualitative detection of SARS-CoV-2 antigen in nasopharyngeal and oropharyngeal samples from NG Biotech is a modern and easy-to-use rapid in vitro diagnostic test for healthcare professionals.
NG Test® SARS-CoV-2 Ag detects a nucleocapsid protein of
SARS-CoV-2. The test is regularly validated for detection of new strains
and mutations such as the VOC202012/1 variant (also known as B.1.1.7 or
“UK strain”). For most recent information please refer to the
instructions for use.
NG Test® SARS-CoV-2 Ag was assessed in clinical studies on nasopharyngeal samples from more than 200 patients, including 100 positive samples, confirmed by RT PCR. The overall specificity was evaluated at 100% with IC95% [96-100%]. Detailed results are presented in the following tables:
Part No. NGB-COV-S23-028 | NG Test® SARS-CoV-2 Ag
20 tests per kit
Please contact your local representative for availability in your country.
Not for sale in the USA.
Manufactured by NG Biotech Laboratories, 35480 Guipry/France. (www.ngbiotech.com)
Hain Lifescience GmbH - a Bruker company
Hain Lifescience Spain SL - a Bruker Company
Biocentric - a Bruker Company
Bruker UK Ltd.